Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2023 · 10-Q
Revenue$275.52M$275.52M+0.4% vs Q3 2022 Net Income$51.95M$51.95M+3.5% vs Q3 2022 EPS Diluted$1.04$1.04+5.1% vs Q3 2022 Gross Profit$150,402,000−3.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$54,942,000−17.1% Free Cash Flowderived$53,139,000−17.1% Margins · derivedGross margin54.6%−1.9 pt vs Q3 2022
Operating margin31.6%+1.6 pt vs Q3 2022
Net margin18.9%+0.6 pt vs Q3 2022
ended Dec 31, 2022 · filed Feb 2, 2023 · 33 d after period end